MedRx Co., Ltd (TSE:4586) announced a private placement of 25,000 units of 13th series warrants at ¥395 per unit for gross proceeds of ¥9,875,000 on April 10, 2018. The transaction will include participation from Barclays PLC Private Banking & Investment Banking Investment. Each warrant unit is exercisable for 100 shares. Each warrant is exercisable into 2,500,000 shares at ¥1,744 per share for gross proceeds of ¥4,346,475,000. The company expects to close the transaction on April 27, 2018. The company will pay expenses legal expenses, value calculation expenses, trust bank expenses, etc. of ¥23,400,000 and will receive net proceeds of ¥4,346,475,000 upon exercise of warrants in the transaction. The warrants are exercisable from May 1, 2018 to May 1, 2019. The company will issue securities through third party allotment method. The transaction has been approved by the board of directors of the company.